Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EGFR mutation and response of lung cancer to gefitinib.

× No keyword cloud information.

40 in total

1. Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells.

Authors: Qiang Zhen; Jun-Feng Liu; Jia-Bao Liu; Ren-Feng Wang; Wei-Wei Chu; Ya-Xiao Zhang; Guo-Liang Tan; Xiao-Jian Zhao; Bao-Lei Lv
Journal: Cancer Biol Ther Date: 2015-04-01 Impact factor: 4.742

Review 2. Surgery for NSCLC in the era of personalized medicine.

Authors: Tetsuya Mitsudomi; Kenichi Suda; Yasushi Yatabe
Journal: Nat Rev Clin Oncol Date: 2013-02-26 Impact factor: 66.675

3. T790M and acquired resistance of EGFR TKI: a literature review of clinical reports.

Authors: Chunyan Ma; Shuzhen Wei; Yong Song
Journal: J Thorac Dis Date: 2011-03 Impact factor: 2.895

Review 4. Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications.

Authors: Oscar Juan; Sanjay Popat
Journal: Ther Adv Med Oncol Date: 2017-01-30 Impact factor: 8.168

5. A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.

Authors: Yasushi Yatabe; Toyoaki Hida; Yoshitsugu Horio; Takayuki Kosaka; Takashi Takahashi; Tetsuya Mitsudomi
Journal: J Mol Diagn Date: 2006-07 Impact factor: 5.568

Review 6. Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers.

Authors: Takayuki Fukui; Tetsuya Mitsudomi
Journal: Gen Thorac Cardiovasc Surg Date: 2008-03-14

7. Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancer.

Authors: Hua-Jun Chen; Tony S Mok; Zhi-Hong Chen; Ai-Lin Guo; Xu-Chao Zhang; Jian Su; Yi-Long Wu
Journal: Pathol Oncol Res Date: 2009-04-21 Impact factor: 3.201

Review 8. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.

Authors: Zdenko Herceg; Pierre Hainaut
Journal: Mol Oncol Date: 2007-03-14 Impact factor: 6.603

Review 9. Clinical-molecular factors predicting response and survival for tyrosine-kinase inhibitors.

Authors: Mariano Provencio; Rosario García-Campelo; Dolores Isla; Javier de Castro
Journal: Clin Transl Oncol Date: 2009-07 Impact factor: 3.405

Review 10. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.

Authors: Kim-Son H Nguyen; Susumu Kobayashi; Daniel B Costa
Journal: Clin Lung Cancer Date: 2009-07 Impact factor: 4.785